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The structure of ergothioneine biosynthetic sulfoxide synthase 
EgtB 
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Abstract: The non-heme iron enzyme EgtB catalyzes O2-dependent 
carbon-sulfur bond formation between -glutamyl cysteine and N--
trimethyl histidine as the central step in ergothioneine biosynthesis. 
Both, catalytic activity and architecture of EgtB are distinct from 
known sulfur transferases or thiol dioxygenases. The crystal 
structure of EgtB from Mycobacterium thermoresistibile in complex 
with -glutamyl cysteine and N--trimethyl histidine reveals the two 
substrates and three histidine residues as ligands of an octahedral 
iron binding site. This active site geometry is consistent with a 
catalytic mechanism in which C-S bond formation is initiated by an 
iron (III)-complexed thiyl radical attacking the imidazole ring of N--
trimethyl histidine. 
Ergothioneine (1, Figure 1) occurs in a broad range of 
prokaryotic and eukaryotic organisms, including humans or 
human pathogens such as Mycobacterium tuberculosis.[1] Higher 
eukaryotes absorb ergothioneine as a micronutrient, which 
stems from microbial production. The precise cellular function of 
ergothioneine is not known, but recent observations on animal, 
fungal and bacterial cells suggest that this sulfur compound may 
be a protectant against oxidative stress.[2] Mycobacteria 
biosynthesize ergothioneine from glutamate, cysteine and 
histidine.[1d, 3] The central step in this pathway is catalyzed by the 
non-heme iron enzyme EgtB which forms and sulfoxidizes a C-S 
bond between N-α-trimethyl histidine (2, TMH) and γ-glutamyl 
cysteine (γGC) using O2 as oxidant. Together with the ovothiol 
(4) biosynthetic enzyme OvoA (Figure 1),[4] EgtB represents a
distinct enzyme class (sulfoxide synthases) with no relation to
sulfur oxidizing or C-S bond forming iron enzymes such as
cysteine dioxygenase or isopenicillin synthase.[5] Instead,
sulfoxide synthases present a new entry to a rich collection of C-
S bond forming catalysts.[6]
To elucidate the structural basis for sulfoxide synthase activity, 
we determined the crystal structure of EgtB from Mycobacterium 
thermoresistibile (EgtBthermo) in complex with iron and TMH, and 
as a quaternary complex with manganese, N-α-dimethyl 
histidine (DMH) and γGC. We produced this enzyme in 
Escherichia coli following the protocols established for the EgtB 
homolog from Mycobacterium smegmatis (EgtBsmegmatis).
[1d] The
Figure 1. EgtB and OvoA catalyzed C-S bond formation and sulfoxidation 
between γ-glutamyl cysteine and N-α-trimethyl histidine (TMH) or between 
cysteine and histidine as the central step in ergothioneine (1) and ovothiol (4) 
biosynthesis.  
two enzymes share 81 % sequence homology, both are 
monomeric (Figure S1) and display similar in vitro activities 
(Table 1). Both recombinant enzymes purified to a significant 
extent as iron-bound holoenzymes as inferred by a ferrozine-
based colorimetric assay (EgtBthermo > 95 %, EgtBsmegmatis > 50 %, 
Table S1) and by titration of EgtB activity with FeSO4 (Figure S2) 
In vitro activity was assayed in HEPES buffered solutions in the 
presence of TMH, GC, 4 M FeSO4, 2 mM ascorbate, 100 mM 
NaCl and 2 mM TCEP at 25°C. Formation or the sulfoxide 
product (3, Figure 1, Figure S3) was monitored by cation-
exchange HPLC.[1d] Under these conditions EgtBsmegmatis and
EgtBthermo catalyzed up to one turnover per second and 
remained active for hundreds of turnovers (Table 1, Figure S3). 
In absence of ascorbate the activity of EgtBthermo ceased after 
120  ± 20 turnovers, but fully recovered after addition of 2 mM 
ascorbate (Figure S4). Incubation with GC alone also 
inactivated EgtBthermo (Figure S4) and induced an absorption 
band at 565 nm (565 = 450 M
-1cm-1, Figure S5) which also
vanished after addition of ascorbate. A similar absorption feature 
has been observed in cysteine-bound ferric cysteine 
dioxygenase where it was assigned as a sulfur to iron (III) 
charge transfer transition.[7] By contrast, no change in activity or 
absorbance was induced by incubation of EgtBthermo with TMH or 
buffer alone. We suspect that a GC-dependent side reaction 
oxidizes EgtB into the inactive ferric state. The absorption at 565 
nm of  
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Table 1. Kinetic parameters of EgtB variants.[a]  
enzyme donor acceptor kcat,donor (s
-1
) [b]   kcat,donor/KM (M
-1
s
-1
) kcat,acceptor(s
-1
) kcat,acceptor/KM(M
-1
s
-1
) 
EgtBsmegmatis γGC TMH 1.1 1.4 x 10
4
 1.2 2.8 x 10
4
 
EgtBthermo γGC TMH 8.6 x 10
-1
 2.0 x 10
4
 8.7 x 10
-1
 2.2 x 10
4
 
EgtBthermo NGC TMH 2.5 x 10
-1
 2.3 x 10
2
 n.a. n.a. 
EgtBD416N γGC TMH 2.7 x 10
-1
 1.3 x 10
2
 1.1 x 10
-1
 1.9 x 10
4
 
EgtBD416N NGC TMH 1.0 x 10
-1
 1.1 x 10
3
 n.a. n.a. 
[a] GC = gamma-glutamyl cysteine; TMH = N-α-trimethyl histidine; NGC = N-glutaryl cysteine; displayed values are averages from 
three independent measurements, errors correspond to less than 15 % of averaged value. [b] kcat and kcat/KM were determined in the 
presence of co-substrate at a concentration at least 3-fold higher than the corresponding KM and in air saturated buffers. Michaelis-
Menten plots are displayed in the supporting information. 
 
 
inactive EgtBthermo in complex with GC provides a first 
indication that the sulfur atom of this ligand may directly 
interact with the catalytic iron center. The following structural 
analysis will provide strong support for this notion. 
 
We crystallized EgtBthermo as apo protein (mthEgtB_apo), in 
complex with iron and TMH (mthEgtB_TMH) and in complex 
with manganese, DMH and GC (mthEgtB_DMH_GC). The 
crystals belong to space group P43212 with cell constants 
a,b=135 and c=141 Å. The apo structure was phased using 
the anomalous signal of the intrinsic sulfur atoms and the 
coordinated iron. The phases were later combined with native 
data to yield the structure of EgtBthermo at resolutions of 1.7 Å 
(apo). Ligand complexes of EgtBthermo were obtained to a 
resolution of 1.6 Å (TMH) and 1.98 Å (GC and DMH). In all 
structures, the asymmetric unit includes two protein chains 
sharing only a relatively small and asymmetric interface. 
The electron densities of the three EgtBthermo structures reveal 
a continuous polypeptide chain from Pro7 to Asp434 (Figure 
2). Residues 7 – 150 fold to a DinB-like four-helix bundle with 
long linkers between helices 1 – 2 (18 residues), 2 – 3 (34 
residues) and 3 – 4 (7 residues). The fourth helix is followed 
by an extended two-stranded -sheet (residues 151 to 210) 
wrapped around the C-terminal domain, which adopts a C-
type lectin fold (CLec).[8] This fold contains few secondary 
structure elements but instead is stabilized by a dense array 
of buried ionic interactions such as salt bridges between Arg 
to Glu residues (Arg409:Glu196; Arg413:Glu296; 
Arg:397:Glu300; Arg428:Glu360). In addition, a calcium 
cation in the center of the C-terminal domain immobilizes 
seven oxygen ligands from side chains and backbone amides 
(Met354, 2.8 Å; Gly399, 2.9 Å; Val358, 2.6 Å; Gly356, 2.7 Å; 
and Gln353, 3.6 Å, Glu360 3.3 Å). This unusual, loop-rich 
structure is conserved in at least two single domain proteins 
with entirely different functions, with less than 30 % sequence 
homology and without dependence on transition metals.[8a, 8c] 
One of these structural homologs (r.m.s.d. of 0.741, Figure S6) 
is the human formylglycine-generating enzyme (FGE) which 
catalyzes O2-dependent posttranslational maturation of 
sulfatases.[8c] The second homolog is the diversity-generating 
retroelement variable protein TvpA from Treponema 
denticola.[9] Iron dependent sulfoxide synthases such as EgtB 
and OvoA must have emerged from these FGE-like proteins 
by fusion with an N- 
 
Figure 2. Cartoon diagram of EgtBthermo in complex with iron (brown) and 
TMH (salmon). The protein consists of an N-terminal DinB domain (grey, 
residues 1 – 150), two-stranded β-sheet region (black, residues 151 – 
210), and a C-terminal C-type lectin domain (cyan/orange, residues 211 – 
434). The active site containing a 3-histidine facial triade (green, His51, 
His134, His138) is formed between the DinB domain and residues 370-425 
(orange) 
terminal DinB domain.  It is not surprising that the EgtB active 
site maps to the interface between the two domains. 
 
The active site of EgtBthermo is housed in a 15 Å deep and 10 
Å wide tunnel lined by residues 375 through 425 from the 
CLec domain and residues from helices 2 and 4 and the 
loops between helices 1, 2 and 3. At the bottom of this tunnel 
three histidines form the DinB domain (residues 51, 134 and 
138) coordinate the catalytic iron cation (Fe-N: 2.1 Å, 2.1 Å 
and 2.3 Å). This structure revises our earlier prediction that 
Glu140 rather than His51 is a metal ligand.[1d, 4a]  
In hindsight, we note that this facial triade is fairly conserved 
among proteins from the DinB protein superfamily.[10] Several 
single domain DinB proteins have been characterized as 
zinc-dependent thiol S-transferase or maleylpyruvate 
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Figure 3. Active site of EgtBthermo in the ternary complex with TMH and iron (left), or with DMH, GC and manganese (right). Localized waters are in red. A 
chloride ion (green) in the ternary complex occupies the cationic docking site of GC. Unbiased difference electron densities of bound ligands are shown in Figure 
S7. 
isomerases,[11] indicating that metal-catalyzed C-S bond 
formation may be a common activity among DinB-like 
proteins.[11a] However, the mechanisms of iron and O2 
dependent oxidative C-S bond formation as catalyzed by 
EgtB and OvoA are most likely very different form that of zinc-
promoted alkyl transfers.[6a, 12] With this hypothesis in mind we 
proceeded to study the substrate binding mode of EgtBthermo.  
 
In the ternary complex containing EgtBthermo, TMH and iron 
(ternary complex) the substrate imidazole ring (Fe-N: 2.2 Å, 
Figure 3) and two water molecules (Fe-O: 2.1 and 2.2 A) join 
the 3-histidine facial triad in an octahedral coordination 
sphere around the iron center. The substrate imidazole ring 
also interacts with Tyr380 through a water-mediated 
hydrogen bond (5.4 Å), and the 1-carboxylate group is loosely 
connected to Arg87 (4.9 Å), again via a bridging water 
molecule. Two N--methyl groups of TMH pack against the 
indole side chain of Trp415. The third N--methyl group 
appears to make dipolar contacts to the amide side chains of 
Gln137 (3.2 Å) and Asn414 (3.5 Å). 
 
To identify the binding mode of the second substrate GC we 
examined the structure of the quaternary complex between 
EgtBthermo, DMH, GC and manganese (II). Initial attempts to 
soak the iron containing binary complex with GC resulted in 
disintegration of the crystals. As a solution to this problem we  
used manganese-reconstituted EgtBthermo. This enzyme 
complex is inactive[1d] but the corresponding crystals were 
tolerant to soaking with DMH and GC and diffracted to a 
resolution of 1.98 Å (Figure 3, Table S2 & S3). In this 
complex the active site residues and DMH adopt 
superimposable positions with respect to the ternary complex 
(r.m.s.d. = 0.041). GC coordinates as the fifth ligand to the 
metal center (Fe-S: 2.6 Å). This direct metal-thiolate contact 
is consistent with the observed sulfur to iron charge transfer 
transition absorption band in the GC complex with ferric 
EgtBthermo (Figure S5). The -amino group and the two 
carboxylates of GC form salt bridges to Asp416 (2.8 Å), 
Arg420 (2.7 Å), Arg87 (3.0 Å) and Arg90 (2.6 Å). The amid 
function of GC hydrogen bonds with the 1-carboxylate of 
DMH (2.8 Å). 
 
To test whether the GC-binding mode in the manganese 
complex properly reflects substrate binding by the iron 
containing and therefore active form of EgtBthermo we probed 
GC binding by site directed mutagenesis. Specifically, we 
produced an EgtBthermo variant with an Asp416 to Asn 
mutation (EgtBD416N). This mutation increases KM,γGC by 200-
fold but does not significantly change KM,TMH or kcat. In a 
complementary experiment we assayed wild type EgtBthermo 
and EgtBD416N with a GC derivative which lacks the -amino 
function (N-glutaryl cysteine, NGC). NGC is a 100-fold less 
efficient sulfur donor for wild type but a 10-fold better 
substrate for EgtBD416N than GC. Evidently, the salt bridge 
between the -amino group of GC and Asp416 found in the 
manganese containing quaternary complex of EgtBthermo is 
also important for substrate recognition during catalysis. 
The sixth metal ligand in the quaternary complex is a water 
molecule (Fe-O: 2.5 Å) which also hydrogen bonds to the 
phenolic side chain of tyrosine 377 (2.8Å). In addition, this 
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Figure 4. Proposed mechanism for EgtB catalyzed C-S bond formation 
and sulfoxidation. 
coordination site maps to the mouth of a narrow tunnel 
connecting the active site with the protein exterior (Figure S8). 
It is tempting to view this tunnel as the path through which O2 
accesses the active site. 
 
Based on the observation that γGC, TMH and possibly O2 are 
direct ligands to the catalytic iron center we propose the 
following mechanism for EgtB catalyzed sulfoxide synthesis 
(Figure 4): Binding of γGC and O2 to the EgtB complex with 
TMH results in an iron (III) superoxo species (a). This species 
may have partial character of iron (III) in complex with a 
peroxide anion (O2
-2) and a thiyl radical (b). The peroxide 
anion is stabilized by proton transfer from Tyr377 and the thiyl 
radical attacks the imidazole ring to form an iminyl radical (c) 
which re-aromatizes by deprotonation and ligand-to-metal 
electron transfer (d). Sulfoxidation of the new thioether 
reduces the iron (II) peroxo species to return EgtB to its 
resting state. 
 
Conclusions. EgtB represents a novel type of non-heme iron 
enzyme which catalyzes oxidative C-S bond formation and 
sulfoxidation. The crystal structure of EgtB provides the basis 
for testing mechanistic proposals by kinetic, spectroscopic 
and computational methods,[13] and also opens the door for 
protein engineering to generate tailor made sulfur 
transferases. Our demonstration that a single mutation 
(Asp416) suffices to change the sulfur donor specificity of 
EgtBthermo from γGC to NGC by almost three orders of 
magnitude bodes well for this objective. We anticipate that 
the structure of EgtB will also stimulate mechanistic 
investigations on the ovothiol biosynthetic sulfoxide synthase 
OvoA.[4] 
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